Study with Brazilian researcher brings future vaccine against malaria vivax to light

Finding of a new blood cell entry changes what is known about P. vivax

The quest for new drugs for forgotten populations is a priority, says Jadel Kratz

In Brazil, only 4% of the clinical studies conducted to date have been focused on neglected diseases. We need an arsenal of new therapies to bring radical change.

Responsible for novel malaria discovery is granted the Clara Southmayd Ludlow Medal

Experiment by Dr. Ruth Nussenzweig with rodents marked the onset of the long search for a vaccine. Despite the discouraging performance of vaccines in the first decades, she never lost hope on immunization

The Aedes is still beating humans and this must be changed

Indicada pela SBMT, Celina Turchi integra a lista tríplice a ser encaminhada ao MCTIC

A epidemiologista coordenou o primeiro estudo que demonstrou a associação entre o Zika vírus e os casos de microcefalia em recém-nascidos

NOTA DE ESCLARECIMENTO 19/01/2018

Sobre a Nota Técnica Conjunta – Vacina Febre Amarela

Tuberculosis: We must join forces to face this global threat

The 2017 world report on tuberculosis showed that nearly 1,7 million people in the world lost their lives in 2016 as an outcome of the disease

NOTA SBMT:

Is the next challenge for the JBSTM to increase its Qualis-Capes?

Evaluation criteria by fostering agencies apply powerful pressure over the process of disclosing national scientific publications. However, there are doubts about its importance for science. Two editors of the BJTM opine about the theme

According to Ulisses Confalonieri, globalization increased emerging diseases’ transmission speed

Research and surveillance strategies in Brazil are important to point to emerging risk situations and indicate disease containment measures